We are live on
!
Find out more
CS
Candriam SCA Portfolio holdings
AUM
$19.3B
1-Year Est. Return
39.18%
This Fund
S&P 500
This Quarter
Est. Return
+4.06%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$8.02B
AUM Growth
+$201M
(+2.6%)
Cap. Flow
-$89M
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
19.81%
Holding
867
New
76
Increased
308
Reduced
302
Closed
63
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$48.8M |
| 2 |
Procter & Gamble
PG
|
+$24.6M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$23.6M |
| 4 |
Keysight
KEYS
|
+$23.2M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$46.5M |
| 2 |
ExxonMobil
XOM
|
+$36.6M |
| 3 |
GG
Goldcorp Inc
GG
|
+$24.9M |
| 4 |
Walt Disney
DIS
|
+$23.8M |
| 5 |
NAVG
Navigators Group Inc
NAVG
|
+$19.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.16% |
| 2 | Technology | 16.87% |
| 3 | Financials | 10.38% |
| 4 | Consumer Discretionary | 9.09% |
| 5 | Communication Services | 7.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
ConocoPhillips
COP
$147B
| $7.13M | 0.09% |
117,341
-101,139
| -46% | -$6.29M |
|
252
Kura Oncology
KURA
$922M
| $7.1M | 0.09% |
362,100
-33,900
| -9% | -$563K |
|
253
Royal Bank of Canada
RY
$291B
| $7.09M | 0.09% |
89,468
-30,718
| -26% | -$2.4M |
|
|
VMW
254
DELISTED
VMware, Inc
VMW
| $7.07M | 0.09% |
42,449
+303
| +0.7% | +$56.8K |
|
255
Regions Financial
RF
$26.3B
| $7.02M | 0.09% |
472,134
-151,110
| -24% | -$2.23M |
|
256
Aflac
AFL
$63.9B
| $6.98M | 0.09% |
69,794
-36,431
| -34% | -$1.88M |
|
257
Best Buy
BBY
$18B
| $6.97M | 0.09% |
100,371
+48,389
| +93% | +$3.38M |
|
|
FITB
258
Fifth Third Bancorp
FITB
$52B
| $6.87M | 0.09% |
247,438
-147,527
| -37% | -$4.04M |
|
259
Devon Energy
DVN
$51.9B
| $6.77M | 0.08% |
238,302
-172,558
| -42% | -$5.13M |
|
260
Occidental Petroleum
OXY
$57B
| $6.72M | 0.08% |
134,225
-13,974
| -9% | -$786K |
|
261
Tyler Technologies
TYL
$12.2B
| $6.71M | 0.08% |
31,202
-14,325
| -31% | -$3.11M |
|
|
ITCI
262
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.69M | 0.08% |
518,000
-140,000
| -21% | -$1.8M |
|
|
DISCK
263
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $6.69M | 0.08% |
236,223
+25,791
| +12% | +$700K |
|
264
Unum
UNM
$13.8B
| $6.65M | 0.08% |
199,130
-81,811
| -29% | -$2.83M |
|
265
Motorola Solutions
MSI
$69.4B
| $6.64M | 0.08% |
40,033
+18,555
| +86% | +$2.8M |
|
|
QIWI
266
DELISTED
QIWI PLC
QIWI
| $6.64M | 0.08% |
341,000
+201,000
| +144% | +$3.22M |
|
267
CSX Corp
CSX
$98.6B
| $6.62M | 0.08% |
215,790
-38,301
| -15% | -$987K |
|
268
Reinsurance Group of America
RGA
$15.7B
| $6.56M | 0.08% |
42,219
-8,898
| -17% | -$1.33M |
|
269
Agilent Technologies
A
$39.1B
| $6.52M | 0.08% |
87,645
-9,911
| -10% | -$734K |
|
270
Morgan Stanley
MS
$337B
| $6.4M | 0.08% |
146,813
+4,944
| +3% | +$220K |
|
|
NOAH
271
Noah Holdings
NOAH
$588M
| $6.4M | 0.08% |
151,000
-192,000
| -56% | -$8.84M |
|
|
LTXB
272
DELISTED
LegacyTexas Financial Group Inc
LTXB
| $6.38M | 0.08% |
+157,388
| New | +$6.17M |
|
|
ONCE
273
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $6.32M | 0.08% |
62,007
+3,007
| +5% | +$324K |
|
274
McCormick & Company Non-Voting
MKC
$13.4B
| $6.32M | 0.08% |
81,854
-70,036
| -46% | -$5.4M |
|
275
Atmos Energy
ATO
$29.9B
| $6.31M | 0.08% |
42,014
+7,630
| +22% | +$781K |
|
Similar funds
PCM
A
MGP
LF
SOMRS
BPA
MIM
Candriam SCA's Q2 2019 Portfolio in Review
As of Q2 2019, Candriam SCA held 867 positions worth $8.02B, up 2.6% from $7.82B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Candriam SCA's Q2 2019 filing shows 76 new, 308 increased, 302 reduced and 63 closed positions. Its largest new stake was Total System Services, Inc.: 112,342 shares worth $14.3M. The largest sale was Celgene Corp, an estimated $46.5M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 33% a quarter earlier, followed by Technology and Financials.
- Candriam SCA's largest Q2 2019 buy was Total System Services, Inc.: 112,342 shares worth $14.3M.
- Candriam SCA added most to Vertex Pharmaceuticals in Q2 2019, an estimated $48.8M increase.
- Candriam SCA's biggest Q2 2019 reduction was Celgene Corp, cutting an estimated $46.5M.
- Candriam SCA fully exited Goldcorp Inc in Q2 2019, selling an estimated $24.9M.
- Candriam SCA's ten largest holdings make up 20% of its $8.02B portfolio in Q2 2019.
- Candriam SCA opened 76 new positions and closed 63 in Q2 2019.
- Candriam SCA's portfolio value rose 2.6% quarter-over-quarter to $8.02B.
Based on Candriam SCA's 13F filing for Q2 2019, filed 1 Aug 2019.